Tecsys makes healthcare supply chain AI tools available

Tecsys has made artificial intelligence functions available to help health systems manage drug purchasing, pharmacy inventory and clinical supplies using data from connected operational systems. Its 20 October TecsysIQ release includes tools for flagging 340B purchasing shortfalls, suggesting transfers of near-expiry inventory, analysing surgical preference cards and reporting clinical supply measures. Several inventory and pharmacy concepts had been previewed at the company’s June user conference; the October development is their current availability and the specification of additional workflows.

Healthcare supply chains span purchasing systems, central warehouses, hospital pharmacies, automated dispensing cabinets and point-of-use records. A pharmaceutical product can appear in a supplier order, a pharmacy inventory account and a cabinet at the same time, but the systems may not share a sufficiently current or consistent view of quantity, location, status and expected usage. That fragmentation complicates decisions about whether to place another order, transfer stock between sites or intervene before products expire. Tecsys says its inventory visibility function combines data from Elite and connected applications to make those decisions from a broader operational record.

The 340B Integrity Agent targets the US federal 340B Drug Pricing Program, under which eligible healthcare organisations obtain qualifying outpatient drugs at statutory discounted prices subject to programme requirements. Tecsys describes the agent as helping users anticipate when compliant purchases of a particular medication may be exhausted, assess urgency and distinguish immediate requirements from purchases that can wait. The distinction is consequential because a purchasing recommendation cannot override eligibility rules or substitute for compliance checks. Federal requirements include preventing diversion to ineligible patients, maintaining auditable records and avoiding duplicate discounts.

Another component, the Hospital Expiry Avoidance Agent, identifies inventory approaching expiry and suggests movement to locations where it has a greater prospect of being used. Tecsys says the calculation also considers the quantity needed at the originating location. In operational terms, a proposed transfer can only be useful if a receiving site has demand, the item remains suitable for use, and there is enough remaining shelf life after transport and processing. Storage conditions, batch traceability, site-specific clinical requirements and local handling rules must still be satisfied. The company has not announced an automatic transfer mandate or quantified reductions in expired stock across a named deployment.

The Preference Card Optimizer examines surgical preference cards against observed use of supplies during procedures. These cards inform the items assembled for particular operations, so excessive or outdated entries can produce unnecessary picking, storage and return work. Comparing listed products with actual consumption may support changes to standard kits, but clinical judgement remains essential because patient and procedure variability can justify carrying items that are not used in every case. Tecsys describes recommendations for perioperative teams, rather than autonomous changes to clinical practice or a replacement for the local approval process.

Clinical Inventory Insights brings measures of case activity, stock and compliance into a dashboard intended for supply chain managers. A common definition of consumption and inventory value can help a hospital group compare departments, but the same stock level can reflect overordering at one site and a justified contingency reserve at another. Interpreting an apparent outlier therefore requires product criticality, patient demand and replenishment lead times alongside the numerical measure. Tecsys has not published a common benchmark or independently assessed customer outcome for the available October functions.

Hospital distribution teams must reconcile demand at individual sites with a shared stock position that may change during a purchasing cycle. Scheduled procedures establish some requirements in advance, while emergency admissions, substitutions and supplier delays can alter the quantities needed before an order or transfer is fulfilled. A replenishment decision therefore depends on current orders in transit, usable stock already reserved and the lead time for obtaining additional product. Central pharmacy and operating theatre supplies follow different replenishment and handling routines, even where both are recorded in one enterprise system. Where a product is scarce, an inventory team may need to agree a facility allocation with clinical staff before arranging physical movement, so that goods reach the appropriate receiving location in usable condition.

Implementation requires hospitals to reconcile product identifiers, units of measure, batch and expiry records, and movement histories across Tecsys Elite and connected pharmacy and enterprise systems. Each organisation must determine who reviews purchasing recommendations, authorises transfers and resolves conflicting inventory records before software outputs affect stock orders. An initial baseline can then distinguish existing losses and processing effort from changes during use: expired-stock write-offs, transfers completed before expiry, unnecessary surgical kit picks and purchasing alerts resolved within 340B rules. Comparisons must account for changes in patient demand, product mix and replenishment patterns, because those conditions affect performance independently of the software. Tecsys has not disclosed implementation costs, a rollout timetable for third-party system connections or verified savings attributable to these October capabilities. The operational results will depend on the quality of connected records and completed decisions at participating facilities.